Literature DB >> 3972295

Prognostic factors in carcinoma of the vulva.

J Boyce, R G Fruchter, E Kasambilides, A D Nicastri, A Sedlis, J C Remy.   

Abstract

The clinical and pathologic characteristics of epidermoid carcinoma of the vulva in 84 women treated by vulvectomy were evaluated in relation to inguinal node status and survival. Tumor diameter, depth of invasion, clinical node status, vascular invasion, and pattern of invasion were all individually correlated with the pathologic status of the inguinal nodes. However, when evaluated in combination, only the clinical status of the inguinal nodes, the depth of invasion, and the pattern of invasion (in this order of significance) were predictive of pathologic inguinal node status. Tumor diameter, inguinal node status, depth of invasion, pattern of invasion, and vascular invasion were individually correlated with survival. When evaluated in combination, the clinical diameter of the lesion was the most important predictor of survival; depth of invasion and vascular invasion contributed additional information.

Entities:  

Mesh:

Year:  1985        PMID: 3972295     DOI: 10.1016/0090-8258(85)90218-5

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study.

Authors:  Pankaj Deka; Debabrata Barmon; Sushrata Shribastava; Amal Chandra Kataki; J D Sharma; M Bhattacharyya
Journal:  J Midlife Health       Date:  2014-01

2.  Prognostic analysis of early-stage squamous cell carcinoma of the vulva.

Authors:  Li-Qun Xu; Rong-Zhen Luo; Xue-Ming Sun; Jie-Hua He; Yan-Na Zhang
Journal:  World J Surg Oncol       Date:  2013-01-26       Impact factor: 2.754

Review 3.  Vulvar carcinoma: dilemma, debates, and decisions.

Authors:  Swarupa Mitra; Manoj Kumar Sharma; Inderjeet Kaur; Ruparna Khurana; Kanika Batra Modi; Raman Narang; Avik Mandal; Soumya Dutta
Journal:  Cancer Manag Res       Date:  2018-01-09       Impact factor: 3.989

4.  Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study.

Authors:  Linn Woelber; Monika Hampl; Christine Zu Eulenburg; Katharina Prieske; Johanna Hambrecht; Sophie Fuerst; Ruediger Klapdor; Sabine Heublein; Paul Gass; Annika Rohner; Ulrich Canzler; Sven Becker; Mareike Bommert; Dirk Bauerschlag; Agnieszka Denecke; Lars Hanker; Ingo Runnebaumn; Dirk M Forner; Fabienne Schochter; Maximilian Klar; Roxana Schwab; Melitta Koepke; Matthias Kalder; Peer Hantschmann; Dominik Ratiu; Dominik Denschlag; Willibald Schroeder; Benjamin Tuschy; Klaus Baumann; Alexander Mustea; Philipp Soergel; Holger Bronger; Gerd Bauerschmitz; Jens Kosse; Martin C Koch; Atanas Ignatov; Jalid Sehouli; Christian Dannecker; Sven Mahner; Anna Jaeger
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

5.  Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study.

Authors:  Linn Woelber; Mareike Bommert; Philipp Harter; Katharina Prieske; Christine Zu Eulenburg; Julia Jueckstock; Felix Hilpert; Nikolaus de Gregorio; Severine Iborra; Jalid Sehouli; Atanas Ignatov; Peter Hillemanns; Sophie Fuerst; Hans-Georg Strauss; Klaus Baumann; Matthias Beckmann; Alexander Mustea; Werner Meier; Sven Mahner; Anna Jaeger
Journal:  Ann Surg Oncol       Date:  2021-03-15       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.